E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/20/2008 in the Prospect News High Yield Daily.

Valeant calls all $300 million outstanding 7% notes

By Devika Patel

Knoxville, Tenn., June 20 - Valeant Pharmaceuticals International announced that it will redeem all of its $300 million outstanding 7% senior notes due 2011 on July 21.

The Bank of New York Trust Co., NA, 700 Flower Street, Suite 500, Los Angeles, CA 90017, is the trustee.

Valeant is a specialty pharmaceutical company located in Costa Mesa, Calif.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.